Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 2, 2014, Pages 152-164

  Madsbad, Sten ^a   Dirksen, Carsten ^a,b   Holst, Jens J ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BARIATRIC SURGERY; BODY WEIGHT; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; METABOLISM; OBESITY;

BARIATRIC SURGERY; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; GLUCOSE; OBESITY;

EID: 84893363785     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70218-3     Document Type: Review

References (128)

1. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001, 161:1581-1586.
2. Despres JP Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox?. J Am Coll Cardiol 2011, 57:1887-1889.
3. Derosa G, Maffioli P Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 2012, 11:459-471.
4. Dixon JB, le Roux CW, Rubino F, Zimmet P Bariatric surgery for type 2 diabetes. Lancet 2012, 379:2300-2311.
5. Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012, 55:1890-1901.
6. Dixon JB, Zimmet P, Alberti KG, Rubino F Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med 2011, 28:628-642.
7. Buchwald H, Oien DM Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013, 23:427-436.
8. Ashrafian H, Bueter M, Ahmed K, et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev 2010, 11:907-920.
9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
10. Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia 2013, 56:1914-1918.
11. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
12. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care 2009, 32:2133-2135.
13. Pournaras DJ, Aasheim ET, Sovik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012, 99:100-103.
14. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013, 23:93-102.
15. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013, 36:20-26.
16. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008, 299:316-323.
17. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012, 366:1567-1576.
18. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013, 36:2175-2182.
19. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012, 366:1577-1585.
20. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013, 309:2240-2249.
21. Burton PR, Brown WA The mechanism of weight loss with laparoscopic adjustable gastric banding: induction of satiety not restriction. Int J Obes (Lond) 2011, 35(suppl 3):S26-S30.
22. Kampe J, Stefanidis A, Lockie SH, et al. Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model. Int J Obes (Lond) 2012, 36:1403-1411.
23. Tadross JA, le Roux CW The mechanisms of weight loss after bariatric surgery. Int J Obes (Lond) 2009, 33(suppl 1):S28-S32.
24. Falken Y, Hellstrom PM, Holst JJ, Naslund E Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab 2011, 96:2227-2235.
25. Jorgensen NB, Dirksen C, Bojsen-Moller KN, et al. The exaggerated glucagon-like peptide-1 response is important for the improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 2013, 62:3044-3052.
26. Dirksen C, Damgaard M, Bojsen-Moller KN, et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil 2013, 25:346. e255.
27. Shah S, Shah P, Todkar J, Gagner M, Sonar S, Solav S Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis 2010, 6:152-157.
28. Bernstine H, Tzioni-Yehoshua R, Groshar D, et al. Gastric emptying is not affected by sleeve gastrectomy-scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg 2009, 19:293-298.
29. Bjorklund P, Laurenius A, Een E, Olbers T, Lonroth H, Fandriks L Is the Roux limb a determinant for meal size after gastric bypass surgery?. Obes Surg 2010, 20:1408-1414.
30. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008, 16:298-305.
31. Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest 2012, 122:4667-4674.
32. Jacobsen SH, Bojsen-Moller KN, Dirksen C, et al. Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals. Diabetologia 2013, 56:2250-2254.
33. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 2013, 98:4391-4399.
34. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012, 22:740-748.
35. Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 2010, 92:704-713.
36. Griffen WO, Young VL, Stevenson CC A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977, 186:500-509.
37. Schwartz A, Doucet E Relative changes in resting energy expenditure during weight loss: a systematic review. Obes Rev 2010, 11:531-547.
38. Benedetti G, Mingrone G, Marcoccia S, et al. Body composition and energy expenditure after weight loss following bariatric surgery. J Am Coll Nutr 2000, 19:270-274.
39. Carrasco F, Papapietro K, Csendes A, et al. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg 2007, 17:608-616.
40. Das SK, Roberts SB, McCrory MA, et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am J Clin Nutr 2003, 78:22-30.
41. Flancbaum L, Choban PS, Bradley LR, Burge JC Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery 1997, 122:943-949.
42. Werling M, Olbers T, Fandriks L, et al. Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS One 2013, 8:e60280.
43. Bueter M, Lowenstein C, Olbers T, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010, 138:1845-1853.
44. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010, 252:966-971.
45. Stylopoulos N, Hoppin AG, Kaplan LM Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 2009, 17:1839-1847.
46. McAlister FA, Man J, Bistritz L, Amad H, Tandon P Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 2003, 26:1518-1524.
47. Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009, 136:1552-1560.
48. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011, 54:2506-2514.
49. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005, 54:603-608.
50. Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010, 33:1438-1442.
51. Foo J, Krebs J, Hayes MT, et al. Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery. Obes Surg 2011, 21:1914-1920.
52. Lips MA, De Groot GH, van Klinken JB, et al. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clin Endocrinol (Oxf) 2013, published online May 27. 10.1111/cen.12254.
53. Jackness C, Karmally W, Febres G, et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes 2013, 62:3027-3032.
54. Lingvay I, Guth E, Islam A, Livingston E Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery?. Diabetes Care 2013, 36:2741-2747.
55. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007, 30:1709-1716.
56. Miras AD, le Roux CW Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol 2013, 10:575-584.
57. Delin CR, Watts JM, Saebel JL, Anderson PG Eating behavior and the experience of hunger following gastric bypass surgery for morbid obesity. Obes Surg 1997, 7:405-413.
58. Wilson-Perez HE, Chambers AP, Sandoval DA, et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes (Lond) 2013, 37:288-295.
59. Zheng H, Shin AC, Lenard NR, et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1273-R1282.
60. Ochner CN, Kwok Y, Conceicao E, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 2011, 253:502-507.
61. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004, 240:236-242.
62. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008, 8:201-211.
63. 2 (LBMI). Obes Surg 2009, 19:307-312.
64. Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013, 341:406-410.
65. Kindel TL, Yoder SM, Seeley RJ, D'Alessio DA, Tso P Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 2009, 13:1762-1772.
66. Cohen R, le Roux CW, Papamargaritis D, et al. Role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes. Diabet Med 2013, 30:1482-1486.
67. Jorgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012, 303:E122-E131.
68. Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-en-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 2012, 26:2231-2239.
69. Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006, 91:1735-1740.
70. Pournaras DJ, Aasheim ET, Bueter M, et al. Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis 2012, 8:371-374.
71. Dirksen C, Hansen DL, Madsbad S, et al. Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes Care 2010, 33:375-377.
72. Jimenez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg 2013, 257:894-899.
73. Shah M, Law JH, Micheletto F, et al. The contribution of endogenous glucagon-like peptide-1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes 2013, published online Oct 2. 10.2337/db13-0954.
74. Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 2012, 22:1084-1096.
75. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007, 92:4678-4685.
76. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008, 93:2479-2485.
77. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010, 34:462-471.
78. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007, 3:597-601.
79. Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011, 7:683-690.
80. Hojberg PV, Vilsboll T, Rabol R, et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia 2009, 52:199-207.
81. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
82. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003, 88:1594-1602.
83. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009, 33:786-795.
84. Dixon AF, Dixon JB, O'Brien PE Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 2005, 90:813-819.
85. Whitson BA, Leslie DB, Kellogg TA, et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res 2007, 142:295-300.
86. Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2013, published online Nov 15. 10.2337/db13-1307.
87. Dirksen C, Bojsen-Moller KN, Jorgensen NB, et al. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass. Diabetologia 2013, 56:2679-2687.
88. Ferrannini E, Mingrone G Impact of different bariatric surgical procedures on insulin action and β-cell function in type 2 diabetes. Diabetes Care 2009, 32:514-520.
89. Camastra S, Muscelli E, Gastaldelli A, et al. Long-term effects of bariatric surgery on meal disposal and ss-cell function in diabetic and nondiabetic patients. Diabetes 2013, 62:3709-3717.
90. Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Increased hepatic insulin clearance after Roux-en-Y gastric bypass. J Clin Endocrinol Metab 2013, 98:E1066-E1071.
91. Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011, 54:2093-2102.
92. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008, 51:1901-1911.
93. Leibel RL Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond) 2008, 32(suppl 7):S98-108.
94. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006, 14:1553-1561.
95. Gerhard GS, Styer AM, Wood GC, et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 2013, 36:1859-1864.
96. Jansen PL, van Werven J, Aarts E, et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig Dis 2011, 29:48-51.
97. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009, 17:1671-1677.
98. Pournaras DJ, le Roux CW Are bile acids the new gut hormones? Lessons from weight loss surgery models. Endocrinology 2013, 154:2255-2256.
99. Ahmad NN, Pfalzer A, Kaplan LM Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) 2013, 37:1553-1559.
100. Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013, 21:E660-E668.
101. Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond) 2013, 37:1452-1459.
102. Kohli R, Setchell KD, Kirby M, et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology 2013, 154:2341-2351.
103. Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 2013, 98:E708-E712.
104. Mencarelli A, Renga B, D'Amore C, et al. Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Diabetes 2013, 62:3384-3393.
105. Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012, 153:3613-3619.
106. Aron-Wisnewsky J, Doré J, Clement K The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol 2012, 9:590-598.
107. Sweeney TE, Morton JM The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013, 148:563-569.
108. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59:3049-3057.
109. Liou AP, Paziuk M, Luevano JM, Machineni S, Turnbaugh PJ, Kaplan LM Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013, 5:178ra41.
110. Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009, 13:1198-1204.
111. Badman MK, Flier JS The gut and energy balance: visceral allies in the obesity wars. Science 2005, 307:1909-1914.
112. Hussain SS, Bloom SR The regulation of food intake by the gut-brain axis: implications for obesity. Int J Obes (Lond) 2013, 37:625-633.
113. Berthoud HR, Zheng H, Shin AC Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann NY Acad Sci 2012, 1264:36-48.
114. Menzies J My brain made me do it, and my gut didn't help. J Neuroendocrinol 2012, 24:1272-1273.
115. Sarzynski MA, Jacobson P, Rankinen T, et al. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) 2011, 35:676-683.
116. Still CD, Wood GC, Chu X, et al. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity (Silver Spring) 2011, 19:1676-1683.
117. Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, Mirshahi T The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2011, 96:E2088-E2096.
118. Hatoum IJ, Greenawalt DM, Cotsapas C, Daly MJ, Reitman ML, Kaplan LM Weight loss after gastric bypass is associated with a variant at 15q26.1. Am J Hum Genet 2013, 92:827-834.
119. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005, 353:249-254.
120. Salehi M, Gastaldelli A, D'Alessio DA Blockade of glucagon-like peptide 1 receptor corrects post-prandial hypoglycemia after gastric bypass. Gastroenterology 2013, published online Dec 3. 10.1053/j.gastro.2013.11.044.
121. Marsk R, Jonas E, Rasmussen F, Naslund E Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 2010, 53:2307-2311.
122. Madsbad S The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications. Diabetes Obes Metab 2014, 16:9-21.
123. Holst JJ, Deacon CF Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 2005, 48:612-615.
124. Sadry SA, Drucker DJ Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol 2013, 9:425-433.
125. Day JW, Ottaway N, Patterson JT, et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol 2009, 5:749-757.
126. Muller TD, Sullivan LM, Habegger K, et al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21. J Pept Sci 2012, 18:383-393.
127. de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013, 23:1354-1360.
128. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752. for the Swedish Obese Subjects Study.